Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease — Stella

Home/Alzheimer Disease/Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease trials

Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Massachusetts General Hospital, Boston, Massachusetts

Key details

Phase

Very early testing

Sponsor

Massachusetts General Hospital

Enrollment target

~30 participants

Started

May 2023

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

40 Years – 99 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.